Obesity and type-2 diabetes in the elderly

被引:9
作者
Dewan, S [1 ]
Wilding, JPH [1 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AL, Merseyside, England
关键词
type-2; diabetes; obesity;
D O I
10.1159/000069176
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Type-2 diabetes is common in the elderly and when compounded by obesity presents a major challenge for the physician. Obesity plays a central role in the aetiology and pathogenesis of type-2 diabetes. Body weight is determined by an interaction between genetic, environmental and psychosocial factors acting through the physiological mediators of energy intake and expenditure. Obesity is thought to predispose to type-2 diabetes primarily by causing insulin resistance. Education and changes in lifestyle remain the key issues in obesity management. Anti-obesity drugs may delay the onset of diabetes but there is limited experience of their use in elderly patients. Obesity should not be viewed as a cosmetic problem that affects a few individuals, but a major health hazard that is both preventable and amenable to treatment. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 64 条
[1]  
[Anonymous], 1998, OB PREV MAN GLOB EP
[2]   DIFFERENT ETIOLOGIES OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS IN OBESE AND NONOBESE SUBJECTS [J].
ARNER, P ;
POLLARE, T ;
LITHELL, H .
DIABETOLOGIA, 1991, 34 (07) :483-487
[3]   FETAL ORIGINS OF CORONARY HEART-DISEASE [J].
BARKER, DJP .
BRITISH MEDICAL JOURNAL, 1995, 311 (6998) :171-174
[4]  
BENNETT N, 1995, HLTH SURVEY ENGLAND
[5]   ETIOLOGY OF OBESITY IN CHILDREN - STUDY OF 101 TWIN PAIRS [J].
BORJESON, M .
ACTA PAEDIATRICA SCANDINAVICA, 1976, 65 (03) :279-287
[6]   THE RESPONSE TO LONG-TERM OVERFEEDING IN IDENTICAL-TWINS [J].
BOUCHARD, C ;
TREMBLAY, A ;
DESPRES, JP ;
NADEAU, A ;
LUPIEN, PJ ;
THERIAULT, G ;
DUSSAULT, J ;
MOORJANI, S ;
PINAULT, S ;
FOURNIER, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (21) :1477-1482
[7]   Sibutramine produces dose-related weight loss [J].
Bray, GA ;
Blackburn, GL ;
Ferguson, JM ;
Greenway, FL ;
Jain, AK ;
Mendel, CM ;
Mendels, J ;
Ryan, DH ;
Schwartz, SL ;
Scheinbaum, ML ;
Seaton, TB .
OBESITY RESEARCH, 1999, 7 (02) :189-198
[8]   Double-blind randomized placebo-controlled trial of sibutramine [J].
Bray, GA ;
Ryan, DH ;
Gordon, D ;
Heidingsfelder, S ;
Cerise, F ;
Wilson, K .
OBESITY RESEARCH, 1996, 4 (03) :263-270
[9]   THE PHARMACOLOGY OF SIBUTRAMINE HYDROCHLORIDE (BTS54524), A NEW ANTIDEPRESSANT WHICH INDUCES RAPID NORADRENERGIC DOWN-REGULATION [J].
BUCKETT, WR ;
THOMAS, PC ;
LUSCOMBE, GP .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) :575-584
[10]   OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN [J].
CHAN, JM ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC .
DIABETES CARE, 1994, 17 (09) :961-969